Improving the care of Lassa fever patients: re-evaluating the use of Ribavirin and characterising cardiovascular function
<p>Lassa fever is a viral haemorrhagic fever, endemic to several West African countries. Case fatality rates average 30% across the literature. Ribavirin, a broad-spectrum antiviral agent, has been used to treat Lassa fever for four decades. Ribavirin is a pro-drug, metabolised to its active m...
第一著者: | Salam, A |
---|---|
その他の著者: | Horby, P |
フォーマット: | 学位論文 |
言語: | English |
出版事項: |
2024
|
主題: |
類似資料
-
Two Cases of Lassa Fever Successfully Treated with Ribavirin and Adjunct Dexamethasone for Concomitant Infections
著者:: Sylvanus Okogbenin, 等
出版事項: (2022-10-01) -
Ribavirin for Lassa Fever Postexposure Prophylaxis
著者:: Christiane M. Hadi, 等
出版事項: (2010-12-01) -
Animal Models of Lassa Fever
著者:: Rachel A. Sattler, 等
出版事項: (2020-03-01) -
Addressing bottlenecks in Lassa fever treatment: overcoming the ribavirin parenteral formulation challenge
著者:: Qudus Olajide Lawal, 等
出版事項: (2024-07-01) -
Bibliometric analysis of global Lassa fever research (1970–2017): a 47 – year study
著者:: Henshaw Uchechi Okoroiwu, 等
出版事項: (2018-12-01)